Neurogene Inc. (NGNE) earnings
NGNE earnings moved a median of -0.43% by the close. Quarterly and annual NGNE reports and results, each read against the price at its own news timestamp. Back to the NGNE overview →
18 measured NGNE earnings events.
Where these NGNE earnings landedvs 16 measured NGNE earnings reactions
| Middle 50% of NGNE earnings reactions | -3.15% to +1.66% |
|---|---|
| Median reaction (to close) | -0.43% |
| Measured reactions | 16 |
Point-in-time · zero look-ahead
Half of the 16 NGNE earnings events with a measured close landed between -3.15% and +1.66%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Neurogene Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.33% | +1.07% | |
| Neurogene Reports Second Quarter 2026 Financial Results and Highlights Recent Updates | Press release | -3.29% | -1.08% | |
| Form 10-Q Neurogene Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.01% | +3.42% | |
| Neurogene Reports First Quarter 2026 Financial Results and Highlights Recent Updates | Press release | +2.01% | +3.42% | |
| Form 10-K Neurogene Inc. For: Dec 31 | SEC filing · Form 10-K | +1.18% | +3.72% | |
| Form 10-Q Neurogene Inc. For: Jun 30 | SEC filing · Form 10-Q | -4.01% | — | |
| Neurogene Reports Second Quarter 2025 Financial Results and Highlights Recent Updates | Press release | -4.01% | — | |
| Form 10-Q Neurogene Inc. For: Mar 31 | SEC filing · Form 10-Q | +3.00% | +0.55% | |
| Neurogene Reports First Quarter 2025 Financial Results and Highlights Recent Updates | Press release | +3.00% | +0.55% | |
| Form 10-K Neurogene Inc. For: Dec 31 | SEC filing · Form 10-K | +4.45% | +0.21% | |
| Form 10-Q Neurogene Inc. For: Sep 30 | SEC filing · Form 10-Q | -13.97% | -17.56% | |
| Neurogene Reports Third Quarter 2024 Financial Results and Highlights Recent Updates | Press release | -13.97% | -17.56% | |
| Form NT 10-Q Neurogene Inc. For: Sep 30 | SEC filing · Form NT | -1.13% | -11.13% | |
| Form 10-Q Neurogene Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.28% | -1.22% | |
| Neurogene Reports Second Quarter 2024 Financial Results and Highlights Recent Updates | Press release | +0.00% | -1.69% | |
| Form 10-Q Neurogene Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -4.52% | |
| Neurogene Reports First Quarter 2024 Financial Results and Highlights Recent Updates | Press release | +0.09% | -2.69% | |
| Form 10-K Neurogene Inc. For: Dec 31 | SEC filing · Form 10-K | +1.22% | +12.93% |
Keep exploring
More NGNE: analyst actions → · SEC filings → · NGNE overview →